Millipore Sigma Vibrant Logo

AGX819 SARS-CoV-2 Spike Protein Recombinant Antigen

COVID-19 Spike Protein Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX819 is used as Positive Control.

View Products on Sigmaaldrich.com
AGX819
100 μg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      Catalogue NumberAGX819
      DescriptionSARS-CoV-2 Spike Protein Recombinant Antigen
      Alternate Names
      • COVID-19
      • 2019-nCoV
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      HS Code3002 15 90
      PresentationPurified protein in Tris Buffer with salts and additives without preservatives, pH 8.0.
      Quality LevelMQ100
      Applications
      ApplicationCOVID-19 Spike Protein Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX819 is used as Positive Control.
      Key Applications
      • Positive Control
      Biological Information
      HostHuman Recombinant
      SpecificitySARS-CoV-2
      Purification MethodAffinity Chromatography
      UniProt Number
      Molecular Weight138 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      AGX819 04061842605903

      Documentation

      SARS-CoV-2 Spike Protein Recombinant Antigen FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      SARS-CoV-2 Spike Protein Recombinant Antigen Certificats d'analyse

      TitreNuméro de lot
      SARS-CoV-2 Spike Protein - 3677719 3677719
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3611072 3611072
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3615444 3615444
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3666024 3666024
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3678862 3678862
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3694761 3694761
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3703595 3703595
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3704755 3704755
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3726525 3726525
      SARS-CoV-2 Spike Protein Recombinant Antigen - 3746854 3746854
      Show more